Retraction Note: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes.

IF 3.4 3区医学 Q2 ENDOCRINOLOGY & METABOLISM Diabetology & Metabolic Syndrome Pub Date : 2025-01-20 DOI:10.1186/s13098-025-01596-w

Jianbin Guan, Haimiti Abudouaini, Kaiyuan Lin, Kaitan Yang

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

关于IL-1抑制剂和秋水仙碱在2型糖尿病炎症控制中的作用的新见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Diabetology & Metabolic Syndrome ENDOCRINOLOGY & METABOLISM-

CiteScore

6.20

自引率

0.00%

发文量

170

审稿时长

7.5 months

期刊介绍： Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome. By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

期刊最新文献

Association between estimated glucose disposal rate with the all-cause and cause-specific mortality among the population with cardiometabolic syndrome. Association of pericoronary inflammation with atherosclerotic plaque progression in diabetic patients with improved modifiable cardiovascular risk factors: a longitudinal CCTA cohort study. Causal relationship of sleep duration on risks for metabolic syndrome: a Mendelian randomization study. Metabolic syndrome including both elevated blood pressure and elevated fasting plasma glucose is associated with higher mortality risk: a prospective study. Stress hyperglycemia ratio: a novel prognostic marker in chronic kidney disease.